The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; AstraZeneca; Celgene; Roche
Tailored dose-dense chemotherapy in combination with trastuzumab as adjuvant therapy for HER2-positive breast cancer: A secondary analysis of the phase III PANTHER trial.
 
Theodoros Foukakis
Honoraria - UpToDate
Research Funding - Pfizer (Inst)
 
Antroula Papakonstantinou
No Relationships to Disclose
 
Alexios Matikas
No Relationships to Disclose
 
Nils-Olof Bengtsson
No Relationships to Disclose
 
Per Malmström
Patents, Royalties, Other Intellectual Property - Participation in royalty sharing agreements PFS Genomics United States
 
Elham Hedayati
Research Funding - Roche (Inst)
 
Guenther G. Steger
Honoraria - Amgen
 
Michael Untch
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai Germany; Lilly; Merck Sharp & Dohme; Mundipharma; Myriad Genetics; Pfizer; Roche Pharma AG; Teva
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Mundipharma (Inst); Odonate Therapeutics; Odonate Therapeutics; Pfizer (Inst); Puma Biotechnology; Roche Pharma AG (Inst)
 
Laila Hübbert
No Relationships to Disclose
 
Hemming Johansson
No Relationships to Disclose
 
Mats Hellstrom
No Relationships to Disclose
 
Michael Gnant
Employment - Sandoz (I)
Honoraria - Amgen; AstraZeneca; Celgene; Lilly; Medison; NanoString Technologies; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Lilly
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Ipsen; Lilly; Medtronic; Pfizer; Roche/Genentech
 
Sibylle Loibl
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Teva (Inst); Vifor Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending EP14153692.0 (Inst)
 
Richard Greil
Honoraria - Amgen; AstraZeneca; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Janssen; Roche
 
Volker Moebus
No Relationships to Disclose
 
Jonas C. S. Bergh
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Other Relationship - UpToDate